Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials

EuroIntervention 2015;10:1425-1431 published online ahead of print February 2014. DOI: 10.4244/EIJV10I12A247

Antoinette De Waha
Antoinette de Waha1*, MD; Lamin A. King1, MD; Giulio G. Stefanini2, MD; Robert A. Byrne1, MD, BCh, PhD; Patrick W. Serruys3, MD, PhD, FESC; Bernhard Meier2, MD; Peter Jüni4, MD; Adnan Kastrati1, MD; Stephan Windecker2,3, MD
1. Deutsches Herzzentrum, Technische Universität and DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany; 2. Department of Cardiology, Bern University Hospital, Bern, Switzerland; 3. Department of Interven

Aims: Arterial plaque rupture and thrombus characterise ST-elevation myocardial infarction (STEMI) and may aggravate delayed arterial healing following durable polymer drug-eluting stent

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

biodegradable polymerbiolimus a9clinical researchmyocardial infarctionsirolimus-eluting stentstent thrombosis
Read next article
Mother-child technique using a novel 4 Fr inner catheter

Latest news